Literature DB >> 23816320

Malaria, clinical features and acute crisis in children suffering from sickle cell disease in resource-limited settings: a retrospective description of 90 cases.

Michel Ntetani Aloni1, Bertin Kadima Tshimanga, Pépé Mfutu Ekulu, Jean Lambert Gini Ehungu, René Makwala Ngiyulu.   

Abstract

BACKGROUND: The prevalence of sickle cell disease (SCD) is extremely high in the Democratic Republic of Congo (DRC). Despite the high prevalence of this disease in our midst, there has been no report on the clinical features in the sickle cell pediatric population suffering from malaria in our midst.
METHODS: A retrospective survey of records from the Department of Paediatrics of the University Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo, was done for the period 1998–2008. For the 10 years studied, 108 children with SCD were reviewed and the data of those who developed malaria during admission were retrieved and analyzed.
RESULTS: Of the 90 homozygous sickle cell children with malaria, fever, pallor, and jaundice were the commonly-found symptoms. Lethargy, severe anemia, respiratory distress, splenomegaly, hepatomegaly,digestive disorders, and prostration were common in children under 5 years, with significant difference (P, 0.05) to the older children. Transfusion because of to severe anemia was found necessary in 54.4% of cases. No case of cerebral malaria was found. Blackwater fever was a rare event. Hand–foot syndrome was present in 12.8% of patients, exclusively in those less than 5 years old. Pain crisis was associated in 46 cases (51.1%). Pain crisis was particularly present in SCD children less than 5 years of age (74.5% vs 25.6%, P , 0.001). No death was observed in this series.
CONCLUSION: We conclude that the acute crisis related to SCD is more common in children less than 5 years of age. High risk of a requirement for blood transfusion was found in young children. Anti-malarial prophylaxis is advocated in Kinshasa.

Entities:  

Mesh:

Year:  2013        PMID: 23816320      PMCID: PMC4001471          DOI: 10.1179/2047773213Y.0000000089

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  10 in total

1.  Abnormal haemoglobins in the Kasai province of the Belgian Congo.

Authors:  J VANDEPITTE; A G MOTULSKY
Journal:  Nature       Date:  1956-04-21       Impact factor: 49.962

2.  High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.

Authors:  Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

3.  Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns.

Authors:  L Tshilolo; L M Aissi; D Lukusa; C Kinsiama; S Wembonyama; B Gulbis; F Vertongen
Journal:  J Clin Pathol       Date:  2009-01       Impact factor: 3.411

4.  Lessons from sickle cell disease in the treatment and control of malaria.

Authors:  Philip J Rosenthal
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

5.  Sickle hemoglobin confers tolerance to Plasmodium infection.

Authors:  Ana Ferreira; Ivo Marguti; Ingo Bechmann; Viktória Jeney; Angelo Chora; Nuno R Palha; Sofia Rebelo; Annie Henri; Yves Beuzard; Miguel P Soares
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

6.  Global epidemiology of haemoglobin disorders and derived service indicators.

Authors:  Bernadette Modell; Matthew Darlison
Journal:  Bull World Health Organ       Date:  2008-06       Impact factor: 9.408

7.  [Infections in Senegalese children and adolescents with sickle cell anemia: epidemiological aspects].

Authors:  I Diagne; G M Soares; A Gueye; N R Diagne-Gueye; L Fall; O N'Diaye; B Camara; S Diouf; M Fall
Journal:  Dakar Med       Date:  2000

8.  Blood transfusion rate in Congolese patients with sickle cell anemia.

Authors:  L M Tshilolo; R K Mukendi; S O Wembonyama
Journal:  Indian J Pediatr       Date:  2007-08       Impact factor: 1.967

9.  Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007.

Authors:  Steve M Taylor; Jane P Messina; Carla C Hand; Jonathan J Juliano; Jeremie Muwonga; Antoinette K Tshefu; Benjamin Atua; Michael Emch; Steven R Meshnick
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Population, behavioural and environmental drivers of malaria prevalence in the Democratic Republic of Congo.

Authors:  Jane P Messina; Steve M Taylor; Steven R Meshnick; Andrew M Linke; Antoinette K Tshefu; Benjamin Atua; Kashamuka Mwandagalirwa; Michael Emch
Journal:  Malar J       Date:  2011-06-09       Impact factor: 2.979

  10 in total
  4 in total

1.  Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.

Authors:  Tite M Mikobi; Prosper Lukusa Tshilobo; Michel N Aloni; Pierre Z Akilimali; Georges Mvumbi-Lelo; Jean Marie Mbuyi-Muamba
Journal:  J Clin Lab Anal       Date:  2017-01-23       Impact factor: 2.352

Review 2.  Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

Authors:  Venée N Tubman; Julie Makani
Journal:  Br J Haematol       Date:  2017-05-11       Impact factor: 6.998

3.  Magnitude of elevated iron stores and risk associated in steady state sickle cell anemia Congolese children: a cross sectional study.

Authors:  Jean-Robert Makulo; Karen Efombola Itokua; Rosette Kevani Lepira; Gloire Mavinga Bundutidi; Michel Ntetani Aloni; René Makuala Ngiyulu; Jean Lambert Gini; François Bompeka Lepira
Journal:  BMC Hematol       Date:  2019-02-08

Review 4.  Hyperhaemolytic Syndrome in Sickle Cell Disease: Clearing the Cobwebs.

Authors:  Anazoeze Jude Madu; Angela Ogechukwu Ugwu; Chilota Efobi
Journal:  Med Princ Pract       Date:  2020-11-11       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.